Molecular Insight Pharmaceuticals, Inc.
USPTO PatentsView assignee record - 23 granted patents across 8 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Molecular ranks #13,057 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 8 technology areas.
- #13,057
- of 49,997 US assignees by volume
- Top 47%
- by Innovation Score (36.0/100)
- 19.6
- avg claims per patent
- -47%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13057 · US Corporation #13,057 · 23 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 23 grants
- MID-PACK #13,057/49,997
- PHOTO-FINISH Metso Sweden AB
- CPC-NARROW A61K · 8 areas
- INNOV-THIN 36.0/100
- CLAIMS-RICH 19.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -47% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Metso Sweden AB (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Molecular’s 36.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Molecular
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Molecular Insight… · this assignee
Molecular Insight… · this assignee
36 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Molecular's Innovation Score is 36.0/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Molecular?
Each dot is one of Molecular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Molecular’s own 19.6 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Molecular's grants concentrate
Molecular Insight Pharmaceuticals, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2017. By volume, Molecular sits between Metso Sweden AB and Nanoprecision Products, Inc..
Molecular's three-year grant acceleration
Molecular Insight Pharmaceuticals, Inc. shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Molecular's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Metso Sweden AB
Metso Sweden AB
23 patents
- Mettler-toledo Ra…
Mettler-Toledo Rainin, LLC
23 patents
- Microcube
MicroCube, LLC
23 patents
- Mighty Buildings
Mighty Buildings, Inc.
23 patents
- Multek
Multek Technologies Limited
23 patents
- Myoscience
MyoScience, Inc.
23 patents
- Nanjing Universit…
Nanjing University OF Technology
23 patents
- Nanoprecision Pro…
Nanoprecision Products, Inc.
23 patents
- Molecular Insight… ◀
Molecular Insight Pharmaceuticals, Inc.
23 patents
What this shows Molecular holds 23 patents at rank #13,055, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Molecular
By rank, the assignees closest to #13,055 in granted patent volume.
- Metso Sweden AB #13,051 · 23 patents
- Mettler-Toledo Rainin, LLC #13,052 · 23 patents
- MicroCube, LLC #13,053 · 23 patents
- Mighty Buildings, Inc. #13,054 · 23 patents
- Multek Technologies Limited #13,056 · 23 patents
- MyoScience, Inc. #13,057 · 23 patents
- Nanjing University OF Technology #13,058 · 23 patents
- Nanoprecision Products, Inc. #13,059 · 23 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Molecular's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Molecular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 17.4% |
| 2016 | 5 | 21.7% |
| 2017 | 1 | 4.3% |
| 2018 | 4 | 17.4% |
| 2019 | 1 | 4.3% |
| 2020 | 3 | 13.0% |
| 2021 | 2 | 8.7% |
| 2022 | 1 | 4.3% |
| 2023 | 2 | 8.7% |
Which technologies does Molecular Insight Pharmaceuticals, Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Molecular Insight Pharmaceuticals, Inc.'s patent record in context - here's where to go next.
- Molecular Insight Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #13,057 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Molecular Insight Pharmaceuticals, Inc. against Metso Sweden AB, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 36.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.